Jacobson Pharmaceuticals (02633.HK) released its annual performance, with a net profit attributable to shareholders of HK$302 million, an increase of 0.26% compared to the previous year.

Wits Financial News App News, Jacobson Pharmaceutical (02633.HK) announced its annual performance for the year ending March 31, 2026. The group achieved revenue of 1.569 billion Hong Kong dollars, a decrease of 0.47% compared to the previous year. The profit attributable to equity holders of the company was 302 million Hong Kong dollars, an increase of 0.26% compared to the previous year. Earnings per share were 15.1 Hong Kong cents, and proposed final dividend per share was 4.75 Hong Kong cents.